Market Access/ Views & Analysis/ Views and analysis IP is no barrier to COVID vaccine access, says industry Amanda Barrell ABPI, COVID-19, IP frameworks 0 Comment While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their Share X IP is no barrier to COVID vaccine access, says industry https://pharmaphorum.com/market-access-2/ip-is-no-barrier-to-covid-vaccine-access-says-industry/
